Delorbis Pharmaceuticals Ltd logo — When it comes to pharmaceuticals, patients come first.

Delorbis Pharmaceuticals Ltd

When it comes to pharmaceuticals, patients come first.

Founded 2014 Cyprus Cyprus 126 employees Biotechnology, Manufacturing +1

General Information

Company Name Delorbis Pharmaceuticals Ltd
Founded Year 2014
Location Cyprus Cyprus +1
Employees 126
Industries Biotechnology, Manufacturing, Pharmaceutical
Social

Get notified when Delorbis Pharmaceuticals Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Delorbis Pharmaceuticals Ltd

Delorbis Pharmaceuticals Ltd is a leading branded generic pharmaceutical company, with a broad portfolio of over 100 pharmaceutical products. The company is dedicated to providing a balanced portfolio of EU-approved branded generics tailored to local therapeutic needs. Operating in more than 35 markets in the Middle East, Africa, Far East, and CIS, Delorbis has established itself as a global player. The company has cultivated strong generic pipelines through global strategic partnerships, facilitating constant growth and identification of product opportunities. Situated in Ergates Industrial Area, Lefkosia, Cyprus, Delorbis's premises house modern facilities equipped with state-of-the-art technology. The manufacturing site comprises two units and one dedicated cytotoxic unit, with departments including production, packaging, quality control, quality assurance, development, and warehouse, all staffed with high-caliber scientific personnel. Operated in full compliance with European-Good Manufacturing Practice (EU-GMP) Rules and Regulations, Delorbis also provides quality control services and contract manufacturing to world-leading pharmaceutical companies. Founded in 1989, Delorbis Pharmaceuticals Ltd remains steadfast in its commitment to putting patients first and offering pharmaceutical products at affordable prices. With its focus on customer satisfaction and continuous growth, Delorbis exemplifies a strong presence in the biotechnology, manufacturing, and pharmaceutical industries.

Taxonomy: Pharmaceuticals, Branded Generics, Quality Control, Product Portfolio, Global Expansion, EU-GMP Compliance, Cytotoxic Unit, Contract Manufacturing, Market Expansion, Strategic Partnerships, Product Opportunities, Middle East Markets, Africa Markets

No funding data available for Delorbis Pharmaceuticals Ltd yet.

Get notified when Delorbis Pharmaceuticals Ltd raises funding

Delorbis Pharmaceuticals Ltd Alternatives & Competitors

Delorbis Pharmaceuticals Ltd vs

Pharmaceutical company | Development, manufacturing and marketing of innovative prescription, generi...

502 employees
Health Care, Manufacturing
Delorbis Pharmaceuticals Ltd vs
LAGAP SA
LAGAP SA Switzerland

a Swiss Pharmaceutical Company

66 employees
Health Care, Pharmaceutical
Delorbis Pharmaceuticals Ltd vs

Innovating patient health with effective and safe pharmaceutical solutions through rigorous research...

11-50 employees
Manufacturing, Pharmaceutical

FAQ About Delorbis Pharmaceuticals Ltd

When it comes to pharmaceuticals, patients come first.
Delorbis Pharmaceuticals Ltd was founded in 2014.
Delorbis Pharmaceuticals Ltd is headquartered in Cyprus.
Delorbis Pharmaceuticals Ltd operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.
Delorbis Pharmaceuticals Ltd has approximately 126 employees.
Top alternatives and competitors to Delorbis Pharmaceuticals Ltd include Dexcel Pharma, LAGAP SA, JP Pharma, Par Pharmaceutical, Avet Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Delorbis Pharmaceuticals Ltd and Dexcel Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Delorbis Pharmaceuticals Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy